ArticleFrontiers in cardiovascular medicine2026
Cerebral hemorrhage after left ventricular assist device implantation in a patient with dilated cardiomyopathy: a case report.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: For patients with end-stage heart failure who have undergone left ventricular assist device (LVAD) implantation, postoperative complications such as cerebral hemorrhage are common, leading to high mortality and complex treatment. Effective blood pressure management and adjustment of anticoagulation targets are crucial in the treatment of cerebral hemorrhage after LVAD implantation. Case presentation: We report the case of a 66-year-old male patient who suffered from a hemorrhagic stroke shortly after the implantation of a domestic LVAD. Intensive blood pressure control was initiated, and the anticoagulation regimen was precisely adjusted. These measures prevented the occurrence of poststroke sequelae, reduced the risk of death, and significantly improved the patient's quality of life. As of the current 5-year follow-up, the patient remains in good general condition. Conclusion: This case provides valuable insights for clinicians managing LVAD patients who experience stroke.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.